18 results · 20ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

“FLNT Base” and “FLNT Temp”

FDA 510(k)
FDA Class 2 ·Dental

M/DN®

FDA UDI
Zimmer, Inc.·00889024044821·

M/DN®

FDA UDI
Zimmer, Inc.·00889024044814·

M/DN®

FDA UDI
Zimmer, Inc.·00889024044838·

M/DN®

FDA UDI
Zimmer, Inc.·00889024044845·

M/DN®

FDA UDI
Zimmer, Inc.·00889024044876·

M/DN®

FDA UDI
Zimmer, Inc.·00889024044883·

M/DN®

FDA UDI
Zimmer, Inc.·00889024044869·

M/DN®

FDA UDI
Zimmer, Inc.·00889024044807·

M/DN®

FDA UDI
Zimmer, Inc.·00889024044852·

M/DN®

FDA UDI
Zimmer, Inc.·00889024044890·

Seiva

FDA UDI
SUNTECH MEDICAL, INC.·10840935109990·

Disposable Surgical Face Mask

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

CONTOUR THREAD SYNTHETIC ABSORBABLE PDO BARBED SUTURE

FDA 510(k)
FDA Class 2 ·General, Plastic Surgery

ENDO GIA ROTICULATOR 60-3.5 SULU

FDA Adverse Event
Injury ·NORTH HAVEN - USS·Product code GDW·December 2, 2008

VERSACARE BED

FDA Adverse Event
Malfunction ·HILL-ROM INC.·Product code FNL·August 3, 2011

MECHANICAL (MANUAL) WHEELCHAIR

FDA Adverse Event
Malfunction ·INVAMEX·Product code IOR·July 29, 2013

Boston Scientific TELIGEN, Implantable Cardiac Defibrillator models E102, E110, the following models are not available in the US: models E103, E111, F102, F103, F110, F111. Sterilized using ethylene oxide. Product Usage: This family of implantable cardioverter defibrillators (ICDs) provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy. Boston Scientific implantable cardioverter defibrillators (ICDs) are indicated to provide ventricular antitachycardia pacing (ATP) and ventricular defibrillation for automated treatment of life-threatening ventricular arrhythmias

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014